Dr Oz says weight-loss shots may help tackle America’s chronic illness crisis CMS administrator Dr. Mehmet Oz discusses the role of GLP-1 medications in combating obesity, saying they can support better health when combined with lifestyle changes and medical guidance.
Pfizer CEO on primary care, GLP-1 outlook and innovation timeline Albert Bourla, Pfizer Chairman & CEO, discusses strong performance in primary care and the game-changing Metsera acquisition for GLP-1 set to launch by 2028 on 'Mornings with Maria.'
Big Medicare change slashes weight-loss drug costs for eligible seniors A new Medicare GLP-1 Bridge program offers Wegovy and Zepbound to eligible seniors for $50 a month starting July 1, slashing obesity drug costs.
Parents turning to GLP-1 drugs for kids as obesity rates soar Fox News senior medical analyst Dr. Marc Siegel discusses the alarming rise of childhood obesity on 'Fox & Friends Weekend' and why some parents are turning to GLP-1 medications like Wegovy to remedy the trend.
'Natural Ozempic' gelatin drink goes viral — dietitian explains what it actually does Drinking warm gelatin before meals is trending as a budget-friendly appetite hack, but a dietitian says comparing it to Ozempic is a massive exaggeration.
GLP-1 weight loss drugs are reshaping the bridal industry as shops rush orders and require new waivers GLP-1 weight loss drugs are transforming the wedding industry as bridal stores handle more rush orders, alterations and waivers for brides' body changes.
Cruise passengers learn diet trick that woman says made her weight loss finally stick To help achieve weight loss that sticks, the Low Carb Cruise features seminars led by health professionals who give recommendations on a high-protein, low-carb diet.
Popular weight loss drugs linked to unexpected male fertility benefit GLP-1 drugs like semaglutide and liraglutide do not appear to suppress male hormones and may boost fertility in obese men, new research suggests.
Weight-loss drugs linked to 'Ozempic ears' and other cosmetic complaints, surgeons say GLP-1 weight loss drugs like Ozempic are linked to cosmetic concerns, including sagging earlobes, deflated breasts and flatter buttocks, surgeons say.
Ozempic users may be making a major weight-loss mistake, new study suggests New research finds GLP-1 users significantly reduced physical activity, with daily steps and exercise declining after starting a weight loss medication.